Theravance Biopharma has been granted a patent for compounds with neprilysin inhibition activity, including prodrugs. The patent also covers pharmaceutical compositions, methods of use, and processes for preparing these compounds. GlobalData’s report on Theravance Biopharma gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Theravance Biopharma Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Theravance Biopharma, was a key innovation area identified from patents. Theravance Biopharma's grant share as of February 2024 was 66%. Grant share is based on the ratio of number of grants to total number of patents.

The granted patent (Publication Number: US11919888B2) discloses a method for producing Compound 6N. The method involves a series of steps, including contacting Compound 1 and a compound with a specific structure. The conditions for the method may include ethyl acetate and acetic acid, as well as other specific reagents such as N,N,N',N'-tetramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluorophosphate and N-ethyl-N-isopropylpropan-2-amine. Additionally, the method may involve the use of acetonitrile and dioxane under certain conditions.

This patent provides a detailed method for the synthesis of Compound 6N, outlining specific steps and conditions required for the process. By specifying the compounds and reagents involved, as well as the conditions necessary for the reaction, the patent offers valuable information for researchers and professionals in the field. The method described in the patent can potentially be utilized in the production of Compound 6N for various applications, highlighting the significance of this innovation in the chemical industry.

To know more about GlobalData’s detailed insights on Theravance Biopharma, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies